Last reviewed · How we verify

Acetaminophen-Hydrocodone

Le Bonheur Children's Hospital · FDA-approved active Small molecule

Acetaminophen reduces fever and pain through central nervous system effects, while hydrocodone is an opioid agonist that binds to mu opioid receptors to provide additional pain relief.

Acetaminophen reduces fever and pain through central nervous system effects, while hydrocodone is an opioid agonist that binds to mu opioid receptors to provide additional analgesia. Used for Moderate pain in pediatric patients, Post-operative pain management in children.

At a glance

Generic nameAcetaminophen-Hydrocodone
Also known asLortab
SponsorLe Bonheur Children's Hospital
Drug classOpioid analgesic combination
TargetMu opioid receptor (hydrocodone component); prostaglandin synthesis inhibition (acetaminophen component)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Acetaminophen's exact mechanism is not fully understood but is believed to involve inhibition of prostaglandin synthesis in the central nervous system and modulation of serotonergic and noradrenergic pathways. Hydrocodone is a semi-synthetic opioid that binds to mu opioid receptors in the brain and spinal cord, reducing the perception of pain and emotional response to pain. The combination provides synergistic analgesic and antipyretic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: